Mostrando 4 resultados de: 4
Publisher
PLoS ONE(1)
Pharmacoepidemiology and Drug Safety(1)
Revista Panamericana de Salud Publica/Pan American Journal of Public Health(1)
The BMJ(1)
Área temáticas
Farmacología y terapéutica(3)
Problemas sociales y servicios a grupos(3)
Medicina y salud(2)
Producción(2)
Funcionamiento de bibliotecas y archivos(1)
Origen
scopus(4)
Data sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study
ArticleAbstract: Purpose: Drug utilization research (DUR) contributes to inform policymaking and to strengthen healthPalabras claves:cross-national, drug utilization research, Latin America, pharmacoepidemiologyAutores:Acosta A., Baldoni A.O., Barberato-Filho S., Beltrán M.M., Cañás M., Castro-Pastrana L.I., Chandia F.V., da Costa Lima E., de Cássia Bergamaschi C., de França Fonteles M.M., de Souza L.J.C., Delgado E.N., Doubova S.V., Dreser A., Elseviers M., Ferre F., Fulone I., Galvão T.F., Gómez-Galicia D.L., Hernández P.G., Herrera-Comoglio R., Leal L.F., Lopes L.C., Luiza V.L., María Belén Mena, Marin G.H., Medero N., Mónica Tarapués, Mota D.M., Olmos I., Osorio-De-Castro C.G.S., Rodríguez-Tanta Y., Roldán-Saelzer J., Salas M., Sánchez-Salgado J.C., Santa-Ana-Tellez Y., Sepúlveda-Viveros D., Silva M.T., Urtasun M.A., Zimmermann I.R.Fuentes:scopusEMA and FDA decisions based on flawed evidence to approve new cancer drugs negatively affect Latin American patients
OtherAbstract:Palabras claves:Autores:Cañás M., Carlos E. Durán, Chistiaens T.Fuentes:scopusRegulatory reliance to approve new medicinal products in Latin American and Caribbean countries
ArticleAbstract: Objective. To describe the current status of regulatory reliance in Latin America and the CaribbeanPalabras claves:Caribbean Region, Drug approval, Government Agencies, Latin America, Pan american health organization, Pharmaceutical preparations, United States Food and Drug AdministrationAutores:Andia T., Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusPotential negative impact of reputed regulators decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
ArticleAbstract: Background Many new cancer drugs are being approved by reputed regulatory authorities without evidenPalabras claves:Autores:Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopus